Fujita, Tetsuo; Satoh, Takefumi; Timme, Terry L et al. (2014) Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models. Urol Oncol 32:92-100
|
Li, Likun; Yang, Guang; Ren, Chengzhen et al. (2013) Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2. Mol Oncol 7:484-96
|
Yang, Guang; Goltsov, Alexei A; Ren, Chengzhen et al. (2012) Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Mol Cancer Res 10:218-29
|
Floryk, Daniel; Kurosaka, Shinji; Tanimoto, Ryuta et al. (2011) Castration-induced changes in mouse epididymal white adipose tissue. Mol Cell Endocrinol 345:58-67
|
Tabata, K; Kurosaka, S; Watanabe, M et al. (2011) Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model. Gene Ther 18:969-78
|
Li, Likun; Ren, Chengzhen; Yang, Guang et al. (2011) GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction. Cancer Res 71:7694-704
|
Thompson, Timothy C (2010) Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potential. Yonsei Med J 51:479-83
|
Langeberg, Wendy J; Tahir, Salahaldin A; Feng, Ziding et al. (2010) Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes. Prostate 70:1020-35
|
Floryk, Daniel; Thompson, Timothy C (2008) Perifosine induces differentiation and cell death in prostate cancer cells. Cancer Lett 266:216-26
|
Tahir, Salahaldin A; Ren, Chengzhen; Timme, Terry L et al. (2003) Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res 9:3653-9
|
Showing the most recent 10 out of 65 publications